TuHURA Biosciences, Inc.
HURA
$3.22
$0.3110.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -56.93% | 41.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.84% | 23.22% | |||
| Operating Income | 14.84% | -23.22% | |||
| Income Before Tax | -42.91% | -11.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -42.91% | -11.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.91% | -11.15% | |||
| EBIT | 14.84% | -23.22% | |||
| EBITDA | 14.86% | -23.35% | |||
| EPS Basic | -39.19% | -8.40% | |||
| Normalized Basic EPS | 17.81% | -8.47% | |||
| EPS Diluted | -39.19% | -8.40% | |||
| Normalized Diluted EPS | 17.81% | -8.47% | |||
| Average Basic Shares Outstanding | 2.65% | 2.55% | |||
| Average Diluted Shares Outstanding | 2.65% | 2.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||